Open Access
CAR+ T-Zell Therapie als mögliche neue Therapieoption für Cisplatin-resistente Plattenepithelkarzinome
Laryngo-rhino-otologiePeer ReviewedZ Poschinski +52021Conference proceedings

The content you want is available to Zendy users.

Already have an account? Sign in
Having issues? Contact support